Baird Medical Showcases Advanced Microwave Ablation Technology at the 2025 ACS Clinical Congress

Core Insights - Baird Medical Investment Holdings Ltd. is participating in the American College of Surgeons Clinical Congress 2025, showcasing its minimally invasive Microwave Ablation technology [1][4] - The ACS is the largest organization for surgeons globally, with over 90,000 members, providing a platform for discussing surgical advancements [2] - Baird Medical is conducting live demonstrations of its MWA devices, highlighting their precision in treating conditions like thyroid nodules and liver cancer [3][4] Company Overview - Baird Medical specializes in minimally invasive diagnostics and treatment, focusing on surgical robotic systems and innovative instruments [5] - The company is FDA 510(k)-certified and has its solutions used in over 30 prestigious hospitals in the U.S., including Johns Hopkins and Weill Cornell Medicine [5] - Baird Medical is a market leader in China for thyroid microwave ablation devices and is expanding its presence in over 20 countries [5]